CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS Journal

publication venue for

Development of a Novel and Robust Pharmacological Model of Okadaic Acid-induced Alzheimer's Disease in Zebrafish. 15:86-94. 2016
Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson's Disease. 14:777-785. 2015
Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid. 14:1343-1349. 2015
Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease. 14:777-785. 2015
Flavonoids Isolated from Rumex aquaticus Exhibit Neuroprotective and Neurorestorative Properties by Enhancing Neurite Outgrowth and Synaptophysin. 13:1458-1464. 2014
Therapeutic Perspectives of Drugs Targeting Toll-Like Receptors Based on Immune Physiopathology Theory of Alzheimer's Disease. 13:909-920. 2014
Flavonoids Isolated from Rumex aquaticus Exhibit Neuroprotective and Neurorestorative Properties by Enhancing Neurite Outgrowth and Synaptophysin. 13:1458-1464. 2014
Therapeutic Perspectives of Drugs Targeting Toll-Like Receptors Based on Immune Physiopathology Theory of Alzheimer’s Disease. 13:909-920. 2014
Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology, and Cognitive Impairments 2021
Overview of Therapeutic Drugs and Methods for the Treatment of Parkinson's Disease 2020
The Interplay between Cofilin and Phospho-Cofilin: Its Role in Maintaining Blood Brain Barrier Integrity 2017

category

NEUROSCIENCES Category
PHARMACOLOGY & PHARMACY Category

International Standard Serial Number (ISSN)

1871-5273

Electronic International Standard Serial Number (EISSN)

1996-3181

journal abbreviation

CNS NEUROL DISORD-DR